Pharma Foods International Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E
|
167.9K | 0.00% | |
|
iShares Trust-iShares International Small-Cap Equity Factor ETF
|
72.4K | +0.56% | |
|
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF
|
13.9K | +2.21% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Small Cap Growth PORT.
|
4.1K | 0.00% | |
|
HOTCHKIS & WILEY Fd.S/DE/-Hotchkis and Wiley Intl Small Cap Diversifie
|
2.8K | 0.00% | |
|
EQ Advisors Trust-EQ/International Value Managed Volatility Portfolio
|
700 | 0.00% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥25 | 0.0% |
| 2025 | ¥25 | 0.0% |
| 2024 | ¥25 | +13.6% |
| 2023 | ¥22 | +10.0% |
| 2022 | ¥20 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Income Statement | |||
| Revenue | ¥60,185M | ¥68,572M | ¥62,147M |
| Gross Profit | ¥48,108M | ¥55,279M | ¥48,751M |
| Operating Income | ¥1,133M | ¥3,684M | ¥5,215M |
| Pretax Income | ¥1,449M | ¥3,590M | ¥5,096M |
| Net Income | -¥374M | ¥3,081M | ¥3,205M |
| EPS | -¥12.89 | ¥106.70 | - |
| Operating Margin | 1.88% | 5.37% | 8.39% |
| Balance Sheet | |||
| Total Assets | ¥31,159M | ¥36,232M | ¥36,573M |
| Total Equity | ¥7,070M | ¥9,630M | ¥11,585M |
| Total Liabilities | ¥24,089M | ¥26,602M | ¥24,988M |
| Cash | ¥8,845M | ¥16,306M | ¥15,666M |
| Interest-bearing Debt | ¥16,857M | ¥20,096M | ¥16,891M |
| Equity Ratio | 22.69% | 26.58% | 31.68% |
| D/E Ratio | 2.38 | 2.09 | 1.46 |
| Cash Flow | |||
| Operating CF | -¥6,065M | ¥6,125M | ¥5,486M |
| Investing CF | -¥2,539M | -¥1,013M | -¥1,390M |
| Financing CF | ¥7,679M | ¥2,341M | -¥4,842M |
| Free CF | -¥6,537M | ¥5,720M | ¥4,513M |
| Efficiency | |||
| ROE | -5.29% | 31.99% | 27.67% |
| ROA | -1.20% | 8.50% | 8.76% |
Latest IR Information
-
Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japan GAAP, Consolidated)
Sales revenue of 48,555 million yen, operating loss of 1,430 million yen, net income attributable to owners of the parent company of -1,061 million yen. Expecting a full-year black ink turning, continuing growth investments. Emphasizing progress on Medium-Term Plan 2026...
Read more -
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP)
Consolidated results for the third quarter of the fiscal year ending July 2026: net sales of 48,455 million yen (up 3.7% year over year), operating loss of 1,430 million yen, ordinary loss of 1,545 million yen, and net loss attributable...
Read more
Latest News (5 items)
Company Information
About
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody and peptide drugs targeting diseases, including autoimmune, cancer, and inflammatory. The company was founded in 1997 and is headquartered in Kyoto, Japan.
